Palo Alto Investors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001306923

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 45 positions · Total reported value $470.00M · Top-10 concentration 75.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.8% · 4 new · 25 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.7% · vs SPY -4.8% · Prev Value $723.72M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.2% · vs SPY -5.3% · Latest Value $672.15M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Palo Alto Investors LP disclosed 45 equity positions with a combined reported value of $470.00M. The filing implies a focused portfolio: its ten largest positions account for 75.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were INSM ($87.06M), ACAD ($55.29M), BMRN ($46.20M). By sector, the heaviest allocations are Health Care 90.8%, Financials 1.5%. Versus the prior quarter, allocation shifted toward Health Care (+5.9pp) and away from Financials (-0.7pp), Other (-5.2pp).

Versus the prior quarter, Palo Alto Investors LP opened 4 new positions, trimmed 25 and fully exited 0, a turnover rate of 51.8% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2025 were IRON ($7.72M), RNAM ($3.38M), DNLI ($3.35M).

Of the 5 positions fully exited versus the prior quarter, the largest were SRPT ($13.42M), SLRN ($4.43M), VERV ($2.63M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • IRON DISC MEDICINE INC · $7.72M
  • RNAM AVIDITY BIOSCIENCES INC · $3.38M
  • DNLI DENALI THERAPEUTICS INC · $3.35M
  • CRSP CRISPR THERAPEUTICS AG · $2.17M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $1.77M
  • ALMS ALUMIS INC · $430.31K

Fully Exited (vs previous quarter)

  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $13.42M
  • SLRN ACELYRIN INC · prev qtr: $4.43M
  • VERV VERVE THERAPEUTICS INC · prev qtr: $2.63M
  • TIL INSTIL BIO INC · prev qtr: $193.82K
  • RLMD RELMADA THERAPEUTICS INC · prev qtr: $133.69K

Insider Transactions (Form 4)

Latest Palo Alto Investors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Palo Alto Investors LP, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 56 positions worth $672.15M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-58166 (status: Approved), registered 2000-12-05
  • Regulatory AUM (Form ADV): $696.00M as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds
  • Website: pa-investors.com

Portfolio Structure

  • 56 positions · $672.15M reported value (Q3 2026)
  • Top 10 holdings = 59.9% of reported value
  • Largest position: PTCT (PTC THERAPEUTICS INC) at 8.4%
  • Average position size: $12.00M

Sector Tilt

  • Health Care 99.8%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 10 added, 25 reduced
  • 17 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 90.8%
Financials 1.5%
Other 7.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 865.11K $87.06M 18.52%
18.52%
Reduce
2 2.56M $55.29M 11.76%
11.76%
Reduce
3 840.47K $46.20M 9.83%
9.83%
Reduce
4 5.61M $32.15M 6.84%
6.84%
Reduce
5 95.48K $27.44M 5.84%
5.84%
Reduce
6 205.76K $25.84M 5.50%
5.50%
Hold
7 75.53K $24.63M 5.24%
5.24%
Reduce
8 406.47K $19.85M 4.22%
4.22%
Add
9 812.82K $18.04M 3.84%
3.84%
Reduce
10 962.40K $17.13M 3.65%
3.65%
Reduce
11 791.88K $13.29M 2.83%
2.83%
Add
12 268.78K $8.94M 1.90%
1.90%
Reduce
13 1.27M $7.74M 1.65%
1.65%
Reduce
14 145.69K $7.72M 1.64%
1.64%
New
15 37.77K $7.15M 1.52%
1.52%
Hold
16 5.74M $7.06M 1.50%
1.50%
Reduce
17 1.58M $6.86M 1.46%
1.46%
Reduce
18 221.02K $6.32M 1.34%
1.34%
Hold
19 3.43M $5.90M 1.25%
1.25%
Add
20 444.37K $4.16M 0.89%
0.89%
Hold
21 118.89K $3.38M 0.72%
0.72%
New
22 239.81K $3.35M 0.71%
0.71%
New
23 64.70K $3.29M 0.70%
0.70%
Hold
24 39.47K $3.09M 0.66%
0.66%
Hold
25 1.25M $2.88M 0.61%
0.61%
Reduce
26 25.21K $2.68M 0.57%
0.57%
Hold
27 264.98K $2.52M 0.54%
0.54%
Reduce
28 44.62K $2.17M 0.46%
0.46%
New
29 1.39M $1.97M 0.42%
0.42%
Add
30 48.75K $1.77M 0.38%
0.38%
New
31 248.93K $1.73M 0.37%
0.37%
Hold
32 13.33K $1.68M 0.36%
0.36%
Hold
33 110.72K $1.64M 0.35%
0.35%
Hold
34 772.65K $1.51M 0.32%
0.32%
Hold
35 125.86K $1.43M 0.30%
0.30%
Hold
36 1.04M $1.14M 0.24%
0.24%
Hold
37 3.98K $974.25K 0.21%
0.21%
Hold
38 225.47K $863.53K 0.18%
0.18%
Hold
39 187.91K $809.90K 0.17%
0.17%
Reduce
40 445.43K $734.97K 0.16%
0.16%
Hold
41 108.86K $618.35K 0.13%
0.13%
Hold
42 143.44K $430.31K 0.09%
0.09%
New
43 24.50K $335.65K 0.07%
0.07%
Hold
44 146.02K $170.83K 0.04%
0.04%
Hold
45 150.47K $48.17K 0.01%
0.01%
Hold

FAQ

What did Palo Alto Investors LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Palo Alto Investors LP reported 45 equity positions worth $470.00M in aggregate; its largest disclosed positions were INSM ($87.06M), ACAD ($55.29M), BMRN ($46.20M).

How large is Palo Alto Investors LP's portfolio?

Palo Alto Investors LP reported $470.00M of long equity holdings across 45 positions as of 2025-Q2. Top-10 holdings account for 75.2% of reported value.

What is Palo Alto Investors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/palo-alto-investors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →